🎉 M&A multiples are live!
Check it out!
| Company | Headquarters | Sector | Stock Price | Enterprise Value | EV/Revenue | EV/EBITDA |
|---|---|---|---|---|---|---|
| Altria Group | United States of America | Tobacco | $58 | $119B | 5.9x | 9.5x |
| Constellation Brands | United States of America | Alcohol | $140 | $34.9B | 3.8x | 10.2x |
| Chart Industries | United States of America | Energy Equipment, Energy Storage, Machinery | $206 | $12.5B | 2.8x | 11.5x |
| ScottsMiracle-Gro | United States of America | Agriculture | $58 | $5.7B | 1.7x | 9.7x |
| Curaleaf | Canada | Cannabis | CAD 3 | $2.7B | 2.1x | 10.1x |
| Green Thumb Indus | Canada | Cannabis | CAD 11 | $2.2B | 1.9x | 6.6x |
| Trulieve | Canada | Cannabis | CAD 12 | $2.0B | 1.7x | 4.8x |
| Tilray Brands | United States of America | Cannabis | $9 | $1.1B | 1.3x | 18.9x |
| Cresco Labs | Canada | Cannabis | CAD 2 | $966M | 1.5x | 6.3x |
| Verano | Canada | Cannabis | CAD 2 | $866M | 1.1x | 3.8x |
| Cannae Holdings | United States of America | Restaurants & Nightlife | $16 | $787M | 1.9x | -5.2x |
| Glass House Brands | Canada | Cannabis | $9 | $752M | N/A | N/A |
| Vireo Growth | Canada | Cannabis | CAD 1 | $728M | 2.8x | 10.2x |
| Ascend Wellness Holdings | Canada | Cannabis | $1 | $684M | N/A | N/A |
| Ayr Wellness | Canada | Cannabis | CAD 0 | $604M | N/A | N/A |
| The Cannabist Company | Canada | Cannabis | CAD 0 | $452M | 1.4x | 19.7x |
| TerrAscend | Canada | Cannabis | CAD 1 | $433M | 1.6x | 6.6x |
| Canopy Growth | Canada | Cannabis, Health & Beauty | CAD 2 | $384M | 1.9x | -41.2x |
| Jushi Holdings | Canada | Cannabis | CAD 1 | $372M | 1.4x | 7.6x |
| SNDL | United States of America | Alcohol, Cannabis | $2 | $360M | 0.5x | 7.7x |
| High Tide | Canada | Cannabis, Pharmacies | CAD 4 | $248M | 0.5x | 8.5x |
| Aurora Cannabis | Canada | Cannabis | CAD 6 | $244M | 0.9x | 5.8x |
| iAnthus Capital | Canada | Cannabis, Drug Development & Therapeutics | CAD 0 | $228M | N/A | N/A |
| Cronos Group | Canada | Cannabis | CAD 4 | $186M | 1.4x | -18.8x |
| Botanix Pharmaceuticals | Australia | Drug Development & Therapeutics, Biopharmaceuticals | AUD 0 | $143M | 8.6x | -3.5x |
| Ispire Technology | United States of America | Tobacco, Cannabis | $3 | $142M | 1.1x | -8.9x |
| Grown Rogue | Canada | Cannabis | CAD 1 | $123M | N/A | N/A |
| MariMed | United States of America | Cannabis, Drug Development & Therapeutics | $0 | $115M | 0.7x | 6.5x |
| Planet 13 Holdings | Canada | Cannabis | CAD 0 | $109M | 1.0x | -8.7x |
| Intercure | United States of America | Drug Development & Therapeutics | $1 | $94.3M | N/A | N/A |
| Mira Pharmaceuticals | United States of America | Drug Development & Therapeutics | $1 | $58.9M | N/A | N/A |
| WM Tech | United States of America | Cannabis, Vertical Marketplaces, Consumer Marketplaces, Food Delivery | $1 | $54.9M | 0.3x | 1.5x |
| Incannex | United States of America | Drug Development & Therapeutics | $0 | $51.6M | 516.1x | -1.4x |
| Forian | United States of America | Healthcare Software | $2 | $37.4M | 1.2x | 36.5x |
| Anebulo Pharmaceuticals | United States of America | Drug Development & Therapeutics | $1 | $30.0M | N/A | N/A |
| SynBiotic | Germany | Nutraceuticals & Cosmeceuticals, Health & Beauty | €3 | $24.0M | 1.2x | -14.0x |
| CFN Enterprises | United States of America | Advertising & Marketing | $2 | $23.1M | N/A | N/A |
| Bakhu Holdings | United States of America | Cannabis | $0 | $14.2M | N/A | N/A |
| Lexaria Bioscience | United States of America | Drug Delivery Systems | $1 | $11.7M | 16.0x | N/A |
| Skye Bioscience | United States of America | Drug Development & Therapeutics | $1 | -$11.7M | N/A | N/A |
Valuation multiples as of last 12 months (LTM). Stock prices as of December 31, 2025. Financial data powered by Morningstar and FactSet.
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.